Table 1 Autopsy case demographics

From: Dissecting α-synuclein inclusion pathology diversity in multiple system atrophy: implications for the prion-like transmission hypothesis

 

Age at onset

Age at death

Pathology diagnosis

NFTs

Aβ plaques

Braak stage

Thal phase

CERAD score

MSA

        

Case 1

68

71

SND/MSA-P

+

+

2

C1

Case 2

35

60

SND/MSA-P

+

1

C0

Case 3

69

77

SND/MSA-P/VaD

+

2

0

C0

Case 4

65

71

OPCA/MSA-C

+

3

C1

Case 5

63

68

SND/MSA-P

Rare

+

1

3

C2

Case 6

57

59

OPCA/MSA-C

+

+

3

2

C2

DLB

Case 1

67

72

DLB/AD

+

+

5–6

3

C2

Case 2

60

68

DLB/AD/CAA

+

+

6

5

C3

Case 3

61

66

DLB/AD/CAA

+

+

4

3

C3

Control

C1

N/A

78

No neuropathology diagnosis

1

0

0

C2

N/A

74

No neuropathology diagnosis

1

0

0

C3

N/A

77

No neuropathology diagnosis

2

0

0

C4

N/A

82

Cerebrovascular arteriolosclerosis

2

2

1

C5

N/A

52

No neuropathology diagnosis

2

2

1

  1. MSA-P multiple system atrophy-(parkinsonism, MSA-C multiple system atrophy-cerebellar), SND striatonigral degeneration, OPCA olivo-ponto-cerebellar atrophy, VaD vascular disease, DLB dementia with Lewy bodies, AD Alzheimer’s disease, CAA cerebral amyloid angiopathy